Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
I would suggest that the disputes are separate. The DHSC are in dispute with GLP and the DHSC are in dispute with ABDX. If the DHSC held back payment to ABDX as a consequence of their dispute with the GLP, they would be adding unwanted prejudice to their case with the latter. I would all assume that if the disputes were related, the RNS would have possibly addressed that point.
Is a takeover highly likely? Would ODX interest the likes of Abbott or Roche? Both sell lft's. What about NCYT, who themselves are about to launch two ltf's, one in Q2 (smart antibody) ?and the other in Q3 (antigen)? They dont manufacture lft'sat the mo! Interesting? Given the pending DHSC contract, is this all too much for the current ODX team? I understand Toyota techies are assisting ODX\RTC, however its a huge leap for them to make given their past performance (not knocking the team, simple reality). My dosh is on a takeover and I`m robustly invested here.
In addition, the current antibody test identify antibodies and cannot advise whether ther are from the vaccine or from the infection. The new 'smart'?antibody test will, apparently, differentiate between the two sets of antibodies detected, if any. I think!!
Not so sure they are that far behind. Their lft antibody test due Q2 and their antigen lft Q3, which is only a few weeks away. Interesting! Having a partner who has already been through the CE process speeds things up... E.g Avacta. Who knows... Watch this space as they say!
Just thing... NCYT have never made an lft before, to my knowledge and they stated they were developing one with a partner?
Does anyone here feel that we could end up making the NCYT antigen lft, which apparently is imminent?
TWatcher.. Its £374m, not £274m, and if you read the contract, there is a `get out' clause. This board if rife with 'hot air, and people who should be on the '?Bet Fair' site If you invested, just switch off and wait¡ It was all explained in a clear and simple RNS today. Straightforward investing: pay your dosh and wait, or sell up and trot on.
Well, could it?
This info on the link supplied on this thread has already been expanded. There are now two additional accreditation phases, 3a and 3b. PHE and the bods at Porton Down have already assessed 120 tests at Phase 3a. There are currently 24 approved tests on the 3a list.
This is very interesting. A good friend of mine is top virologist and suggested to me in February that Covid will be around for another 3 to 5 years. This report helps me to understand her belief.
https://www.ndtv.com/world-news/pfizer-jab-has-5-times-less-antibodies-against-covid-delta-variant-lancet-study-2456362
Rocquet. Not sure that your post is altogether correct re Avacta and Mologic.
Reg. I believe that the Mologic test is in the PHE Phase 3a accredition system at Porton Down. I am led to believe that the Avacta test is not. There are 22 tests with current PHE Phase 3a accreditation at Porton Down. Avacta reported that they did not think they would meet the required deadline to be included in the DHSC tender.
And.... Dont forget the assistance from Toyota too!
A very positive RNS. Key words.... `self-collected swab specimens'. This is what will assist PHE and the Bods at Porton Down. Phase 3a has to be 'idiot proof'?for home use!
Roc.. I think you are a little confused. The AVACTA note refers to its CE mark, where it is being assisted by Mologic. If you refer to ODX making the sovereign test, AVACTA are way off at the moment and have reported via their BOD's that they believe that they may miss the tender timelines. Avacta will need Phase 3a acceditation from the folks at Porton Down. A lengthy process!
Yes we are stuck in the same queue re assessment for Phase 3a accreditation. However, I was just pointing out that Avacta are not anywhere near the front of the queue and have acknowleged they are NOT in the running. Fours additional tests were accredited yesterday!
Four new antigen tests were added to the DHSC phase 3a accreditation (Porton Down)? `pass' list on 26th May. Avacta was not one of them!
Comp 909. I think you are confused. May I help you. Avacta achieved CE marking for their antigen test for frofessional use. They applied to DHSC for registration of this test, which is a rapid process. That means they get the go ahead to market/ sell their test for professional use. To become involved in the Sovereign Test they need 'home use'?approval. This is obtained from acheiving Stage 3a accreditation from Porton Down. Avacta are saying that they will not have time to achieve stage 3a accreditation in time as its a lenghy process and there is a backlog of companies trying to gain stage 3a accreditation. Hope this helps.
Yes, i recall the comments too re 'no further news'. I think that many commentators here have no idea and are simply guessing or have 'other'?motives. If they were that knowledgeable and successful they would not be spending hours on share BB's!